| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO And Treasurer
2 companies
Krognes Steve E. is a Director at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,339 | $20.81 | $69,484.59 | -11.5% | -45.2% | -20.0% | |
| Dec 31, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 30,000 | $20.25 | $607,500.00 | -50.8% | -33.3% | -19.0% | |
| Sep 30, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 30,000 | $29.03 | $870,900.00 | -50.8% | -30.5% | -50.2% | |
| Aug 20, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,727 | $23.79 | $41,085.33 | -5.0% | +2.2% | -38.6% | |
| Jul 1, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 30,688 | $22.11 | $678,659.52 | -20.2% | +32.3% | -36.6% | |
| Apr 1, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 92,500 | $20.50 | $1,896,250.00 | -66.1% | +7.1% | -40.2% | |
| Feb 13, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,750 | $17.29 | $47,547.50 | -1.9% | +13.1% | +22.0% | |
| Jan 5, 2024 | DNLI Denali Therapeutics Inc. | Director | Sell | 3,208 | $19.43 | $62,331.44 | -2.2% | -1.8% | +9.9% | |
| Aug 21, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 1,419 | $22.60 | $32,069.40 | -1.0% | -17.5% | +1.6% | |
| Feb 13, 2023 | DNLI Denali Therapeutics Inc. | Director | Sell | 2,119 | $30.10 | $63,781.90 | -1.5% | +6.1% | -43.5% |